Surrogate endpoints in early prostate cancer research

Clinical research into clinically-localized prostate cancer (PC) is a highly challenging environment. The protracted durations and large numbers required to achieve survival endpoints have placed much pressure on validating early surrogate endpoints. Further confounding is the predominance of deaths...

Descripción completa

Detalles Bibliográficos
Autor principal: Williams, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043744/
https://www.ncbi.nlm.nih.gov/pubmed/30050805
http://dx.doi.org/10.21037/tau.2018.05.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043744/
https://www.ncbi.nlm.nih.gov/pubmed/30050805
http://dx.doi.org/10.21037/tau.2018.05.10

Ejemplares similares